Found 13 matching trials
Novel Triple-dose Tuberculosis Retreatment Regimen
PHASE3To determine if a high-dose first-line regimen is non-inferior (non-inferio...
Location
Damien Foundation
Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
NATuberculosis (TB) patients often have a lower body mass index (BMI) and exp...
Location
Multiple Locations
ATORvastatin in Pulmonary TUBerculosis
PHASE2Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Location
National Tuberculosis Reference Laboratory
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
PHASE2The purpose of this study is to assess pharmacokinetic parameters of atorva...
Location
National Tuberculosis and Leprosy Training Centre, Saye
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
PHASE3DATURA trial is a phase III, multicenter, two-arm, open-label, randomized s...
Location
National Center for HIV/AIDS, Dermatology and STD (NCHADS)
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
PHASE2The goal of this clinical trial is to evaluate 3 dose levels of TBAJ876 for...
Status
Active Not Recruiting
Location
National Center for Tuberculosis and Lung Diseases
Four Months Moxifloxacin Containing Daily Regimen Study Among New Pulmonary Tuberculosis Patients
N/AThe 4-month daily regimen containing moxifloxacin (2HRZEM 7 / 2HRM7) of ICM...
Location
National Institute for Research in Tuberculosis
Pharmacokinetic Study of Linezolid for TB Meningitis
PHASE2Tuberculosis meningitis (TBM) is the most severe manifestation of TB, resul...
Location
Hasan Sadikin General Hospital
Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
PHASE2Tuberculosis (TB) treatment is long and complex with the risk of poor treat...
Location
Linköping University Hospital
Study of Combinations of Novel Promising Drugs for Pulmonary Tuberculosis
PHASE2A phase 2, two-part, multicentre, open label, controlled, randomised clinic...